✦ LIBER ✦

Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation

✍ Scribed by P. M. Llorca; J.-L. Fernandez

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness Evaluation in Sweden

✍ Göran Nordström; Natalya Danchenko; Nicolas Despiegel; Florence Marteau 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 810 KB

PMH27 COST-EFFECTIVENESS OF ESCITALOPRAM

✍ Kulp, W; Greiner, W; Schulenburg, JM 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

PMH25 COST-EFFECTIVENESS OF ESCITALOPRAM

✍ N Despiégel; N Danchenko; K Maman 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

A cost-effectiveness model of escitalopr

✍ Koen Demyttenaere; Michiel E.H. Hemels; Joumana Hudry; Lieven Annemans 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 860 KB

PMH46 COST-EFFECTIVENESS ANALYSIS OF ESC

✍ W Kulp; M Hemels; W Greiner; J Schulenburg Graf von der 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PMH26 COST-EFFECTIVENESS ANALYSIS OF ESC

✍ ME Hemels; O Karamustafaloglu; E Ozmen; S Dilsad; S Mene 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB